DIN 02550962 — LORAZEPAM INJECTION, USP 4 MG
LORAZEPAM INJECTION, USP is a solution of Lorazepam marketed by FRESENIUS KABI CANADA LTD. The full Lorazepam monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02550962
- Brand name
- LORAZEPAM INJECTION, USP
- Active ingredient
- Lorazepam
- Strength
- 4 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Manufacturer
- FRESENIUS KABI CANADA LTD
- Health Canada status
- MARKETED
- Drug class
- Benzodiazepine (anxiolytic-sedative)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Lorazepam products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00655740 | APO-LORAZEPAM | 0.5 MG | TABLET | APOTEX INC | MARKETED |
| 00655759 | APO-LORAZEPAM | 1 MG | TABLET | APOTEX INC | MARKETED |
| 00655767 | APO-LORAZEPAM | 2 MG | TABLET | APOTEX INC | MARKETED |
| 02243278 | LORAZEPAM INJECTION USP | 4 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02410745 | LORAZEPAM SUBLINGUAL | 0.5 MG | TABLET | AA PHARMA INC | MARKETED |
| 02410753 | LORAZEPAM SUBLINGUAL | 1 MG | TABLET | AA PHARMA INC | MARKETED |
| 02410761 | LORAZEPAM SUBLINGUAL | 2 MG | TABLET | AA PHARMA INC | MARKETED |
| 00728187 | PMS-LORAZEPAM | 0.5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 00728195 | PMS-LORAZEPAM | 1 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 00728209 | PMS-LORAZEPAM | 2 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 00655643 | PRO-LORAZEPAM | 0.5 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 00655651 | PRO-LORAZEPAM | 1 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 00655678 | PRO-LORAZEPAM | 2 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 00711101 | TEVA-LORAZEPAM | 0.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 00637742 | TEVA-LORAZEPAM | 1 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 00637750 | TEVA-LORAZEPAM | 2 MG | TABLET | TEVA CANADA LIMITED | MARKETED |